MYCN and neuroblastoma: In contrast to this model where the cells are subcutaneously injected into the flank of mice, Cohen et al. developed a NB model system by micro-injecting human pluripotent stem cell-derived NC cells with conditional MYCN and ALK expression in utero into developing mouse embryos.